$79.590
+0.207 (+0.26%)At close
ZTS News
ZTS Events
Zoetis Receives FDA Approval for Convenia RTU for Dogs
Zoetis announced that the U.S. FDA has approved Convenia RTU for Dogs for the treatment of susceptible bacterial skin infections in dogs. For many families, administering oral antibiotics daily for one to two weeks can be difficult, especially when a dog resists medication or a household schedule makes routine timing hard to maintain. Convenia RTU for Dogs provides up to 14 days of antibiotic treatment in a single dose for susceptible bacterial skin infections in dogs and is administered by a veterinary health professional, supporting complete dose compliance.
U.S. 10-Year Treasury Yield Falls to Near One-Month Lows
The yield on the U.S. 10-year Treasury note fell on Tuesday, hovering near one-month lows, following weaker housing data while investors also continued to assess persistent inflationary pressures ahead of the Fed's interest rate decision next week. Housing starts fell 5.2% in September, while pending home sales dropped to a record low, reflecting the continued strain of elevated mortgage rates on housing demand. The Fed is widely expected to leave interest rates unchanged next week, while markets anticipate a 25 basis point rate hike in December. Meanwhile, crude oil prices moved lower and stocks turned higher following an unconfirmed report from Qatari newspaper Al-Araby Al-Jadeed that Qatar and Pakistan presented a mediation proposal to address the demands of the U.S. and Iran.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:General Motorsreported better-than-expected Q3 sales and earnings and approved a new $20B share repurchase planGE Aerospace posted a "beat and raise" Q3 reportSalesforceagreed to acquire Brazefor $5.66B in enterprise value, or $47.50 per share in cashByteDance, Alibabaand Tencenthave ordered over 3M NvidiaRTX PRO 5500 graphics cards for over $35B, Reuters reportsIndustrial conglomerate 3Mlifted its annual profit forecast as cost-control initiatives and higher prices support margins2. WALL STREET CALLS:Loop Capital downgraded Appleto Hold on iPhone concernsAkamaiupgraded to Strong Buy at Raymond James following recent pullbackBarclays downgraded NuScale Powerto Underweight on commercial delaysBlackRockupgraded to Buy at TD CowenJefferies downgraded Elancoand Zoetisto Hold3. AROUND THE WEB:NRx Pharmaceuticalsis advancing Ketafree, a preservative-free ketamine formulation, and is seeking FDA approval while arguing that benzethonium chloride, a preservative used in most ketamine products, poses health risks, a claim it has not substantiated with evidence, NY Times saysTelesat'screditors have proposed a C$3.2B deal to help the company pay down a coming debt maturity and avert a default, WSJ reportsAustralia is set to sue Meta'sFacebook, TikTok, as well as other major digital platforms for not complying with the country's social media ban for children under 16, Bloomberg saysAlphabet'sWaymo, which currently operates about 4,000 cars, is looking to use the $5B it has recently borrowed to expand its fleet to 8,000 vehicles by the end of 2026 and grow that number to 20,000 by the end of 2027, Semafor reportsNetflixis overhauling its creative leadership in hopes of getting domestic audiences to watch more of its content, WSJ reports4. MOVERS:Myriad Genetics (MYRD) gains after announcing it will sell its Prenatal Health testing business to LabcorpHertzincreases after announcing Oro Mobility secured an $80M strategic equity investment from a consortium of investorsEquifaxhigher after reporting Q3 results, providing guidance for Q4, and narrowing its outlook for FY26Borr Drillinglower after Fearnley downgraded the stock to HoldBaxterfalls after the FDA issued a warning letter following an inspection of its facility5. EARNINGS/GUIDANCE:RTXreported Q3 results and raised its guidance for FY26Krogerbacked its guidance for FY26Ally Financialreported Q3 results, with EPS and revenue beating consensusValmontreported Q3 results and increased its outlook for FY26, with CEO Avner Applbaum commenting this was "another quarter of sales and earnings growth"Genuine Partsreported Q3 results and narrowed its guidance for FY26INDEXES:Near midday, the Dow was up 513.06, or 0.99%, to 52,479.09, the Nasdaq was up 76.22, or 0.29%, to 26,507.11, and the S&P 500 was up 35.46, or 0.46%, to 7,726.19.
Zoetis Appoints Iris Knobloch to Board of Directors
Zoetis (ZTS) announced the appointment of Iris Knobloch to its Board of Directors, effective as of December 1, 2026. Knobloch currently serves on the boards of Deezer, Lazard, and Vail Resorts (MTN), and has built a track record of effective governance across complex, global organizations.
Zoetis' Simparica Trio Outperforms NexGard Plus in Heartworm Study
New peer-reviewed findings published in the journal Parasites & Vectors show that Zoetis' Simparica Trio protected more dogs from adult heartworm infection than NexGard Plus in a controlled, head-to-head laboratory study against the ML-resistant Dirofilaria immitis ZoeLA isolate. In the study, 24 dogs were experimentally challenged with the drug-resistant heartworm isolate and then given one of the two products or a negative control every month for six months at the standard labeled dosage. At the end of the study, one adult heartworm was found in just 2 of the 8 Simparica Trio-treated dogs, compared to one adult heartworm found in 6 of the 8 NexGard Plus-treated dogs.
SoftBank Plans Up to $20B Bond Offering for Refinancing
Funding momentum in AI infrastructure and next‑generation interfaces continues, with Groq and Wispr AI both securing major rounds that push their valuations deeper into unicorn territory.This week's private company news:SoftBankis talking with investment banks about a potential $10B-$20B bond offering to help refinance a loan for itsinvestment in OpenAI, Bloomberg's Laura Benitez and Janice Huang. Proceeds from the sale would partly be used to repay a $40B bridge loan secured earlier this year for its OpenAI investment, and also for other AI investments, according to people familiar with the matter. The offering could be denominated in dollars and euros and could come as early as September, the people add.Anthropicis preparing to pitch amore than $30T total addressable marketin its IPO, surpassing SpaceX's $28.5T estimate and underscoring the exceptionally ambitious growth expectations embedded in AI valuations, The Wall Street Journal's Corrie Driebusch. Anthropic could aim to raise as much as $100B in its offering and is aiming for a valuation of about $2%, the report says.Smart ring makerOurawants up to$3B in its IPOand is targeting avaluation of over $16Bfrom the public listing, Bloomberg's Bailey Lipschultz and Mark Gurman report, citing people familiar with the matter. The IPO could happen as soon as September, the authors note.Some of the biggest capital raises by private companies this week include:Groq– The company announced a $350M Series A fundraise, with the round led by Disruptive, with planned participation from Nvidia. The funding round values the company at $3.5B. This latest round, together with $650M raised in June 2026, brings recent funding in the company to $1B. Publicly-traded companies operating in the same space include Nvidia, AMD, and Broadcom.Wispr AI– The company has raised $280M in Series B funding at a $2B valuation, led by long-time investor and partner Menlo Ventures. They are joined by existing investors Notable Capital, NEA, Neo Ventures, 8VC, and MVP Ventures. Publicly-traded companies operating in the same space include Meta Platforms, Alphabet, and Microsoft.Muon Space– The Mission Foundry for high-performance satellite constellations announced a $250M Series C led by Eclipse Capital, with participation from Galvanize, Google, Salesforce Ventures, Wellington Management, I Squared Capital, Woven Capital, Radical Ventures, Congruent Ventures, Costanoa Ventures, Activate Capital, ACME Capital, ArcTern Ventures, and Overlap Holdings. Publicly-traded companies operating in the same space include Iridium, Spire Global, and Trimble.Starcloud– The company pioneering data centers in space has announced a $250M Series A extension funding round at a $2.3B post-money valuation. The round was led by Manhattan West. Publicly-traded companies operating in the same space include Viasataand AST SpaceMobile.Emerald AI– The company announced it has raised $150M in an oversubscribed Series A financing at a valuation of $1.05B. Energize Capital and DCVC co-led the round. The round was led by Manhattan West. Publicly-traded companies operating in the same space include Palantirand Amazon.Unicorns to watch this week:Halter– The cattle tech/AgTech company has significantly expanded its scale in 2026, raising $220M in a Series E at a $2B valuation, more than doubling its prior valuation. The company now has one million smart collars sold and is operating across three continents, with U.S. ranchers building 60,000 miles of virtual fencing using its system. Publicly-traded companies operating in the same space include Zoetis.Decagon– The AI customer support agent company valuation has tripled to $4.5B following a $250M Series D led by Coatue and Index Ventures. Publicly-traded companies operating in the same space include Salesforce, Freshworks, and HubSpot.Zama– The cryptography/blockchain infrastructure remains the first unicorn in the FHE space, with its Series B round establishing a valuation around $1B. The company continues to push encrypted computation and confidential smart‑contract infrastructure, making it one of the most closely watched cryptography startups in 2026. Publicly-traded companies operating in the same space include Inteland AMD.Colossal Biosciences– The biotech "de-extinction" continues to attract major investor attention as it advances its synthetic biology platform and de extinction programs. Publicly-traded companies operating in the same space include Ginkgo Bioworksand Twist Bioscience.Breeze Aviation Group– The company remains a private standout in U.S. aviation, expanding its fleet and underserved route strategy. Breeze continues to benefit from strong seasonal demand and its growing Airbus A220 footprint, keeping it in focus as a next generation low cost carrier. Publicly-traded companies operating in the same space include Southwest Airlinesand JetBlue Airways.IPOs to watch:OPENAI– The company's CFO Sara Friar told employees that the AI lab "will be a public company in 2027," CNBC's Ashley Capoot and Kate Rooney report. In an all hands meeting, Friar told employees not to worry about rival Anthropic's IPO timeline. OpenAI confidentially filed its IPO prospectus with regulators in June, but it has not publicly disclosed its plans. "The IPO is not a finish line, it is a milestone, another fundraise," Friar told employees, according to two sources familiar with her comments. "We raised $122B in March, and that gives us flexibility."EvoAir Holdings– The company has filed for a firm commitment initial public offering of shares of common stock and anticipates that the initial public offering price of shares will be between $4.00 and $5.00 per share.Inspire Brands– The company announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock. Inspire Brands expects to use the net proceeds of the proposed offering to repay outstanding indebtedness under its existing term loan facility and pay offering fees and expenses."Private Markets" is The Fly's recurring series of stories on the latest moves in the private sector, largest unicorn companies and initial public offerings to watch. Fly subscribers, add $PRIVATE to your portfolio for alerts on breaking news in the startup and venture capital space.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.





